Futures Analysis
1
On-Chain Data
1
Technical Indicators
2
Institutional Data
1

Lite Strategy

Clinical-stage pharmaceutical company(NASDAQ: LITS)

About Lite Strategy

Founded2018

Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.

Community
Twitter
Website
Tags
Publicly listed company
Crypto Stocks

Trend of Hot Index Change

Fundrasing details

Post-IPO(2025-07-21)
Amount$100.00M
Valuation--